Congratulations to the newest Damon Runyon Quantitative Biology Fellows, five exceptional early-career scientists who are using the tools of computational science to generate and interpret cancer research data at extraordinary scale and resolution. Learn more about the new Fellows and their projects here: https://bit.ly/3Z9Vun4 (fb)

Last month, the 2025 Timmerman Traverse for Damon Runyon team successfully completed a challenging trek to Everest Base Camp. The journey to 17,500 feet of altitude was the last step in months of preparation, training, and fundraising in support of Damon Runyon's young cancer researchers. The Timmerman Traverse wouldn't be possible without the generous support of our institutional and corporate sponsors. Sending a mountain of gratitude to all the supporters of the 2025 Timmerman Traverse, who helped our Everest climbers exceed their goal and raise nearly $800k for cancer research! 🏔 Bristol Myers Squibb Kite, A Gilead Company Alnylam Arsenal Capital Partners Cooley LLP DCVC Higgins Group, Inc. Hlx Life Sciences Io Bio KMAK Capital Latham & Watkins LincSwitch Therapeutics Lumanity Lyfe Capital NeoGenomics Laboratories Nucleate pH Foundation PhaseV Relation Therapeutics TD Securities WilmerHale Aragen Life Sciences Argot Partners Bain Capital Life Sciences BioInvent International AB British Land PLC Causaly @danahercorporation Life Sciences Emily Whitehead Foundation ImmunoPrecise Antibodies Lonza Group Nurix Therapeutics OrbiMed Recursion Pharmaceuticals Saras Capital Singular Biotech TCG Lifesciences Pvt. Ltd. (fb)